Osmotic challenges in the assessment of bronchial hyperresponsiveness.
It is now well recognized that a change in osmolarity of the periciliary fluid is a potent stimulus to airway narrowing and may be a common cause for provoking an attack of asthma. This has led to the use of nonisotonic aerosols to document bronchial hyperresponsiveness in patients with clinical asthma. These aerosols are generated by ultrasonic nebulizers, and the most commonly used are water, hyperosmolar sodium or potassium chloride, and dextrose. An increase in specific airway resistance of 100% or a reduction in FEV1 of 20% is considered as an abnormal response to these aerosols. There are a number of factors that affect the airway response to these aerosols, and these include the osmolarity of the solution and its ionic content and pH. In addition responses may be affected by a previous challenge or medication. It is not known precisely how these aerosols act to induce airway narrowing, but it is not by a direct action on smooth muscle. It is thought that a change in osmolarity of the airways causes the release of inflammatory mediators, which then act to narrow the airways. For this reason challenge by nonisotonic aerosols is different from challenge by histamine and methacholine and may be preferable for the diagnosis of asthma and assessment of its treatment.
Anderson
S D
SD
Department of Thoracic Medicine, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
Smith
C M
CM
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000336:Aerosols; D001985:Bronchial Provocation Tests / Q000379:methods; D016084:Bronchoconstriction / Q000187:drug effects*; D002121:Calcium Channel Blockers / Q000494:pharmacology; D005665:Furosemide / Q000494:pharmacology; D006801:Humans; D007552:Isotonic Solutions; D016210:Methacholine Chloride / Q000494:pharmacology; D009994:Osmolar Concentration
D000318:Adrenergic beta-Agonists; D000336:Aerosols; D002121:Calcium Channel Blockers; D007552:Isotonic Solutions; D016210:Methacholine Chloride; D005665:Furosemide